Incyte

Money

Incyte Stock Sinks as Sales Forecast for Key Drugs Falls Short

Key Takeaways Shares of Incyte slumped Monday after the drugmaker’s fourth-quarter adjusted profit and 2025 sales forecasts missed analysts’ expectations.…

Read More »
Back to top button